DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.
Companies / A••••
A••••
Stage unknownUS
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- unknown
- Rounds on record
- 1
- Disclosed raised
- $5.0Msum of rounds with a disclosed amount only
- Named investors
- 1
Financing history
1 rounds
- Jan 12, 2026Funding round · $5.0M (disclosed)O••••• S•••••• E••••••••• (lead)Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) · “A•••• Raises $5M to Apply Causal AI Across Complex Drug Reformulation”
Investors on record
1 edges
- O••••• S•••••• E••••••••• round, lead Fact prnewswire.com
People
0 officers, 0 directors
No officer or director on record.
Timeline
1
- Jan 12, 2026A•••• announced Funding round of $5,000,000, led by O••••• S•••••• E•••••••••Round announced Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
Evidence
1 observations
Every observation on this company
- Round announced: Funding round $5,000,000 Jan 12, 2026 Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)